Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats

Abstract

Opioids are effective analgesics in the management of severe pain. However, tolerance, leading to dose escalation and adverse effects are significant limiting factors in their use. The role of peripheral opioid receptors in analgesia has been discussed especially under inflammatory conditions. The results from pharmacological and conditional knockout studies together do not provide a clear picture of the contribution of peripheral opioid receptors on antinociceptive tolerance and this needs to be evaluated. Therefore, we studied whether the peripherally restricted opioid receptor antagonist, methylnaltrexone (MNTX), could prevent morphine tolerance without attenuating the antinociceptive effect of morphine. Male Sprague-Dawley rats were treated for 7 days with increasing subcutaneous doses of morphine (5-30 mg/kg) and were coadministered saline, MNTX (0.5 or 2 mg/kg), or naltrexone (NTX; 2 mg/ kg). Nociception was assessed with tail-flick, hotplate, and von Frey tests. Morphine, MNTX, and NTX concentrations in the plasma, brain, and spinal cord were measured

Ferroptosis inhibitor ferrostatin-1 attenuates morphine tolerance development in male rats by inhibiting dorsal root ganglion neuronal ferroptosis

“…Despite findings from certain studies, such as those conducted by Zöllner et al [ 48 ] and Blomqvist et al [ 49 ], which suggested that chronic morphine administration might not always induce tolerance in the peripheral nervous system, the present study focused on investigating the specific changes occurring in the DRG. This particular area has been relatively less explored compared to central mechanisms, and the authors aimed to address this gap in the literature.…”

The effects of chronic high-dose morphine on microgliosis and the microglial transcriptome in rat spinal cord

“…On these days, PFA-perfused samples of SCs were collected. All animals were first transcardially perfused with PBS for 3 minutes under isoflurane anaesthesia, 38 after which perfusion with 4% PFA was carried out for 15 min. After excision, PFA-perfused tissues were submerged in 4% PFA solution, which was changed after one and 3 days.…”

Tackling the opioid crisis: Novel mechanisms and clinical perspectives

“…Long-term opioid use is further mired by the risk of analgesic tolerance, opioid-induced hyperalgesia, and dependence (Burma et al, 2017). Blomqvist et al (2020) report that peripheral antagonism of opioid receptors is not sufficient to prevent morphine tolerance, implicating central rather than peripheral mechanisms in opioid tolerance. Lewter et al (2020) then tackle the problem of opioid physical dependence by developing an innovative nanoparticle approach for sustained release of naloxone; they find that slow release reduces the severity of withdrawal in morphine-dependent mice.…”